Evidence map›Paper›PMID 39048805›Full record

ArticleEJNMMI radiopharmacy and chemistry2024

Generic semi-automated radiofluorination strategy for single domain antibodies: [

Herlinde Dierick, Laurent Navarro, Hannelore Ceuppens, Thomas Ertveldt, Ana Rita Pombo Antunes, Marleen Keyaerts, Nick Devoogdt, Karine Breckpot, Matthias D'Huyvetter, Tony Lahoutte and 2 more

Abstract read
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Automated and manual synthesis of [EJNMMI radiopharmacy and chemistry · 2026
    Article
  2. Article
  3. Article
  4. Rapid cleavage of 6-[EJNMMI radiopharmacy and chemistry · 2025
    Article
  5. Review
  6. Simple and Efficient Synthesis ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Herlinde DierickMolecular Imaging and Therapy Research Group (MITH), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103. Building K., 1090, Brussels, Belgium. herlinde.dierick@vub.be.ORCID http://orcid.org/0000-0002-8558-2569
Laurent NavarroPrecirix NV, Burgemeester Etienne Demunterlaan 3, 1090, Brussels, Belgium.
Hannelore CeuppensLaboratory for Molecular and Cellular Therapy (LCMT), Department of Biomedical Sciences, Translational Oncology Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103. Building E, 1090, Brussels, Belgium.
Thomas ErtveldtMolecular Imaging and Therapy Research Group (MITH), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103. Building K., 1090, Brussels, Belgium.
Ana Rita Pombo AntunesPrecirix NV, Burgemeester Etienne Demunterlaan 3, 1090, Brussels, Belgium.
Marleen KeyaertsMolecular Imaging and Therapy Research Group (MITH), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103. Building K., 1090, Brussels, Belgium.
Nick DevoogdtMolecular Imaging and Therapy Research Group (MITH), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103. Building K., 1090, Brussels, Belgium.
Karine BreckpotLaboratory for Molecular and Cellular Therapy (LCMT), Department of Biomedical Sciences, Translational Oncology Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103. Building E, 1090, Brussels, Belgium.
Matthias D'HuyvetterMolecular Imaging and Therapy Research Group (MITH), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103. Building K., 1090, Brussels, Belgium.
Tony LahoutteMolecular Imaging and Therapy Research Group (MITH), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103. Building K., 1090, Brussels, Belgium.
Vicky CaveliersMolecular Imaging and Therapy Research Group (MITH), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103. Building K., 1090, Brussels, Belgium.
Jessica BridouxMolecular Imaging and Therapy Research Group (MITH), Vrije Universiteit Brussel (VUB), Laarbeeklaan 103. Building K., 1090, Brussels, Belgium.

Funding

Fonds Wetenschappelijk Onderzoek 1230824NFonds Wetenschappelijk Onderzoek 12H3619NFonds Wetenschappelijk Onderzoek 1801619NFonds Wetenschappelijk Onderzoek 1S06622NFonds Wetenschappelijk Onderzoek I001618NFonds Wetenschappelijk Onderzoek I005622NInnoviris 2020-RDIR-1Vrije Universiteit Brussel IOF3009Vrije Universiteit Brussel IOF3018Vrije Universiteit Brussel SRP50Vrije Universiteit Brussel SRP62Vrije Universiteit Brussel SRP95
6 · The paper itself

Abstract

backgroundRadiofluorination of single domain antibodies (sdAbs) via N-succinimidyl-4-[

results[

conclusion[

Indexed as

AutomationBiomoleculesFluorine-18Single domain antibodies

Identifiers

PMID39048805
PMCPMC11269545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.